Vanguard Group Inc. Acquires 55,246 Shares of DocGo Inc. (NASDAQ:DCGO)

Vanguard Group Inc. boosted its holdings in DocGo Inc. (NASDAQ:DCGO) by 1.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,672,582 shares of the company’s stock after buying an additional 55,246 shares during the period. Vanguard Group Inc.’s holdings in DocGo were worth $24,905,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the business. BlackRock Inc. increased its position in DocGo by 6.6% in the 2nd quarter. BlackRock Inc. now owns 6,029,276 shares of the company’s stock worth $56,494,000 after buying an additional 373,332 shares during the period. Deerfield Management Company L.P. Series C increased its position in DocGo by 55.7% in the 3rd quarter. Deerfield Management Company L.P. Series C now owns 4,764,000 shares of the company’s stock worth $25,392,000 after buying an additional 1,705,000 shares during the period. Emerald Advisers LLC increased its position in DocGo by 6.4% in the 3rd quarter. Emerald Advisers LLC now owns 2,406,714 shares of the company’s stock worth $12,828,000 after buying an additional 145,163 shares during the period. WCM Investment Management LLC increased its position in DocGo by 77.6% in the 3rd quarter. WCM Investment Management LLC now owns 2,234,689 shares of the company’s stock worth $12,000,000 after buying an additional 976,656 shares during the period. Finally, Punch & Associates Investment Management Inc. grew its holdings in shares of DocGo by 4.4% during the 3rd quarter. Punch & Associates Investment Management Inc. now owns 2,055,359 shares of the company’s stock worth $10,955,000 after purchasing an additional 85,860 shares in the last quarter. 56.44% of the stock is owned by institutional investors.

DocGo Price Performance

Shares of DCGO stock opened at $3.26 on Friday. The stock’s fifty day simple moving average is $3.73 and its 200 day simple moving average is $4.70. The firm has a market cap of $339.59 million, a price-to-earnings ratio of 46.57, a P/E/G ratio of 0.34 and a beta of 0.91. DocGo Inc. has a one year low of $2.78 and a one year high of $10.82.

DocGo (NASDAQ:DCGO) last announced its quarterly earnings results on Wednesday, February 28th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.13 by ($0.07). The company had revenue of $199.25 million during the quarter, compared to analyst estimates of $195.48 million. DocGo had a net margin of 1.10% and a return on equity of 2.01%. On average, research analysts anticipate that DocGo Inc. will post 0.35 earnings per share for the current year.

Insider Activity at DocGo

In other DocGo news, Director Michael J. Burdiek acquired 10,000 shares of the business’s stock in a transaction on Thursday, March 14th. The stock was purchased at an average price of $3.61 per share, for a total transaction of $36,100.00. Following the transaction, the director now owns 571,595 shares in the company, valued at approximately $2,063,457.95. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 13.78% of the stock is owned by insiders.

Analyst Ratings Changes

DCGO has been the topic of several recent research reports. BTIG Research decreased their price objective on DocGo from $13.00 to $11.00 and set a “buy” rating on the stock in a report on Wednesday. Cantor Fitzgerald decreased their price objective on DocGo from $13.00 to $11.00 and set an “overweight” rating on the stock in a report on Thursday, February 29th. Stifel Nicolaus decreased their price objective on DocGo from $11.00 to $8.00 and set a “buy” rating on the stock in a report on Wednesday. Canaccord Genuity Group decreased their price objective on DocGo from $10.00 to $9.00 and set a “buy” rating on the stock in a report on Thursday. Finally, Needham & Company LLC decreased their price objective on DocGo from $14.00 to $10.00 and set a “buy” rating on the stock in a report on Thursday, February 29th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $10.83.

DocGo Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.